These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 38239356)

  • 41. Polymeric nanoparticles: A study on the preparation variables and characterization methods.
    Crucho CIC; Barros MT
    Mater Sci Eng C Mater Biol Appl; 2017 Nov; 80():771-784. PubMed ID: 28866227
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nanoparticles in Combating Cancer: Opportunities and Limitations. A Brief Review.
    Pedziwiatr-Werbicka E; Horodecka K; Shcharbin D; Bryszewska M
    Curr Med Chem; 2021; 28(2):346-359. PubMed ID: 32000637
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nanomaterials for cancer therapy: current progress and perspectives.
    Cheng Z; Li M; Dey R; Chen Y
    J Hematol Oncol; 2021 May; 14(1):85. PubMed ID: 34059100
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chiral nanomaterials for tumor therapy: autophagy, apoptosis, and photothermal ablation.
    Peng Z; Yuan L; XuHong J; Tian H; Zhang Y; Deng J; Qi X
    J Nanobiotechnology; 2021 Jul; 19(1):220. PubMed ID: 34294083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Liposomes and inorganic nanoparticles for drug delivery and cancer imaging.
    Heneweer C; Gendy SE; Peñate-Medina O
    Ther Deliv; 2012 May; 3(5):645-56. PubMed ID: 22834408
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Functional DNA-containing nanomaterials: cellular applications in biosensing, imaging, and targeted therapy.
    Liang H; Zhang XB; Lv Y; Gong L; Wang R; Zhu X; Yang R; Tan W
    Acc Chem Res; 2014 Jun; 47(6):1891-901. PubMed ID: 24780000
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nanoplatform-Mediated Autophagy Regulation and Combined Anti-Tumor Therapy for Resistant Tumors.
    Yang C; Ding Y; Mao Z; Wang W
    Int J Nanomedicine; 2024; 19():917-944. PubMed ID: 38293604
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ultrasound-Mediated Cancer Therapeutics Delivery using Micelles and Liposomes: A Review.
    Mukhopadhyay D; Sano C; AlSawaftah N; El-Awady R; Husseini GA; Paul V
    Recent Pat Anticancer Drug Discov; 2021; 16(4):498-520. PubMed ID: 34911412
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carbon Nanomaterials for Targeted Cancer Therapy Drugs: A Critical Review.
    Hosnedlova B; Kepinska M; Fernandez C; Peng Q; Ruttkay-Nedecky B; Milnerowicz H; Kizek R
    Chem Rec; 2019 Feb; 19(2-3):502-522. PubMed ID: 30156367
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent advancements in the targeted delivery of etoposide nanomedicine for cancer therapy: A comprehensive review.
    Fathi-Karkan S; Arshad R; Rahdar A; Ramezani A; Behzadmehr R; Ghotekar S; Pandey S
    Eur J Med Chem; 2023 Nov; 259():115676. PubMed ID: 37499287
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chitosan nanoparticle-mediated co-delivery of shAtg-5 and gefitinib synergistically promoted the efficacy of chemotherapeutics through the modulation of autophagy.
    Zheng Y; Su C; Zhao L; Shi Y
    J Nanobiotechnology; 2017 Apr; 15(1):28. PubMed ID: 28399862
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nanocarriers for anticancer drugs--new trends in nanomedicine.
    Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R
    Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nanotechnology for Targeted Drug Delivery to Treat Osteoporosis.
    Kaur M; Nagpal M; Aggarwal G
    Curr Drug Targets; 2023; 24(1):2-12. PubMed ID: 36200208
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trends in Nanomedicines for Cancer Treatment.
    do Nascimento T; Todeschini AR; Santos-Oliveira R; de Souza de Bustamante Monteiro MS; de Souza VT; Ricci-Júnior E
    Curr Pharm Des; 2020; 26(29):3579-3600. PubMed ID: 32186271
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nanomedicine for Treatment of Lung Cancer.
    Hussain S
    Adv Exp Med Biol; 2016; 890():137-47. PubMed ID: 26703803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nanomedicine strategies for sustained, controlled and targeted treatment of cancer stem cells.
    Gao J; Li W; Guo Y; Feng SS
    Nanomedicine (Lond); 2016 Dec; 11(24):3261-3282. PubMed ID: 27854161
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeted therapy for leukemia based on nanomaterials.
    Qian S; Zheng C; Wu Y; Huang H; Wu G; Zhang J
    Heliyon; 2024 Aug; 10(15):e34951. PubMed ID: 39144922
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intracellular and extracellular targets as mechanisms of cancer therapy by nanomaterials in relation to their physicochemical properties.
    Andraos C; Gulumian M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Mar; 13(2):e1680. PubMed ID: 33111484
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surface-active liposomes for targeted cancer therapy.
    Sofou S
    Nanomedicine (Lond); 2007 Oct; 2(5):711-24. PubMed ID: 17976032
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent Advances in Nanomaterials Development for Nanomedicine and Cancer.
    Abbasi Kajani A; Haghjooy Javanmard S; Asadnia M; Razmjou A
    ACS Appl Bio Mater; 2021 Aug; 4(8):5908-5925. PubMed ID: 35006909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.